Position in NVO
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,699,233
+$396,630 QoQ
Shares Held
35,445
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#413
of 1,352 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Brooklands Fund Management Ltd holds $4,525,793 across 2 Drug Manufacturers - General names. NVO ranks #2 (37.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMRN |
Amarin Corp Plc\Uk
|
177,325 | $2,826,560 | |
| 2 | NVO |
Novo Nordisk A S
This page
|
35,445 | $1,699,233 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,699,233 | 35,445 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,302,603 | 35,445 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,804,713 | 35,470 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||